tiprankstipranks
L'Oreal (LRLCY)
OTHER OTC:LRLCY
Want to see LRLCY full AI Analyst Report?

L'Oreal (LRLCY) Price & Analysis

282 Followers

LRLCY Stock Chart & Stats

$85.27
-$1.01(-1.19%)
At close: 4:00 PM EDT
$85.27
-$1.01(-1.19%)

Bulls Say, Bears Say

Bulls Say
High And Stable MarginsSustained very high gross and operating margins reflect durable brand pricing power, scale economics, and premium mix across categories. This structural margin advantage supports reinvestment capacity and long-term return on capital even amid cyclical demand shifts.
E‑commerce Leadership & Channel MixLeading e‑commerce penetration is a structural competitive advantage: it broadens geographic reach, raises customer lifetime value, improves gross margin mix, and enables data-driven innovation and marketing, supporting durable market-share gains across channels and regions.
Strong Cash Generation And FCF CoverageConsistent operating cash flow and high FCF coverage underpin capacity to fund R&D, elevated A&P, dividends and M&A without structural liquidity strain. Reliable cash generation supports strategic investments and shareholder returns over the medium term.
Bears Say
Rising Net Debt And LeverageHigher net debt and a noted step-up in 2025 modestly reduce financial flexibility and increase sensitivity to higher rates. While leverage remains manageable, sustained elevated debt constrains optionality for large buybacks or aggressive bolt-on M&A over the next 2–6 months.
Galderma PPA Amortization Dilutes Reported EPSMaterial PPA amortization creates recurring accounting dilution that will depress reported EPS and complicate year‑over‑year comparability. This persistent non‑operational drag can obscure operational progress and affect near‑term metrics used by investors and analysts.
Elevated A&P Intensity Pressures Near‑term MarginsA sustained step‑up in A&P to defend innovation and launches supports long‑term growth but compresses reported net margins and free cash flow in the medium term. If elevated spend persists, margin recovery could be slower despite strong gross margin base.

L'Oreal News

LRLCY FAQ

What was L'Oreal’s price range in the past 12 months?
L'Oreal lowest stock price was $79.51 and its highest was $94.92 in the past 12 months.
    What is L'Oreal’s market cap?
    L'Oreal’s market cap is $241.38B.
      When is L'Oreal’s upcoming earnings report date?
      L'Oreal’s upcoming earnings report date is Feb 11, 2027 which is in 193 days.
        How were L'Oreal’s earnings last quarter?
        L'Oreal released its earnings results on Jul 29, 2026. The company reported $1.703 earnings per share for the quarter, missing the consensus estimate of $1.723 by -$0.02.
          Is L'Oreal overvalued?
          According to Wall Street analysts L'Oreal’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does L'Oreal pay dividends?
            L'Oreal pays a Annually dividend of $1.682 which represents an annual dividend yield of 1.93%. See more information on L'Oreal dividends here
              What is L'Oreal’s EPS estimate?
              L'Oreal’s EPS estimate is 1.48.
                How many shares outstanding does L'Oreal have?
                L'Oreal has 2,661,932,600 shares outstanding.
                  What happened to L'Oreal’s price movement after its last earnings report?
                  L'Oreal reported an EPS of $1.703 in its last earnings report, missing expectations of $1.723. Following the earnings report the stock price went up 0.117%.
                    Which hedge fund is a major shareholder of L'Oreal?
                    Currently, no hedge funds are holding shares in LRLCY
                    What is the TipRanks Smart Score and how is it calculated?
                    Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

                      L'Oreal Stock Smart Score

                      Company Description

                      L'Oreal

                      L'Oréal S.A., a prominent global enterprise, specializes in the development, production, and worldwide distribution of a diverse range of cosmetic and personal care goods catering to both male and female consumers. Its business activities are structured into four key segments: Consumer Products, L'Oréal Luxe, Professional Products, and Active Cosmetics. The company's extensive product portfolio includes hair cleansing and conditioning treatments, styling aids, shower gels, various skincare formulations, facial cleansers, deodorants, sun protection items, and a broad selection of makeup and perfumes. These offerings are marketed under numerous acclaimed brands, such as L'Oréal Paris, Garnier, Maybelline, Lancôme, Kiehl's, Vichy, and La Roche-Posay, among many others. L'Oréal distributes its products through a wide array of channels, including professional hair salons, large-scale retail outlets, specialized perfumeries, department stores, pharmacies, drugstores, medispas, dedicated brand stores, travel retail locations, and via its significant e-commerce presence. Established in 1909, L'Oréal S.A. maintains its corporate headquarters in Clichy, France.

                      L'Oreal (LRLCY) Earnings & Revenues

                      LRLCY Company Deck

                      LRLCY Earnings Call

                      Q2 2026
                      0:00 / 0:00
                      Earnings Call Sentiment|Positive
                      The call emphasized multiple strong operational achievements: robust adjusted like‑for‑like growth (6.5%), record operating margin (21.3%), high e‑commerce growth (18% to EUR 7.4bn), strong division and regional performance (Professional +11.6%, Derm +10.6%, SAPMENA +13.8%), and solid cash generation (operating net cash flow +13.9%). Key challenges were manageable but notable: FX headwinds (-2.8%), sizeable nonrecurring charges (-EUR 430m), heavier A&P investment (+70bps), increased net debt and cash outflows for acquisitions/dividends (free cash flow impact), and accounting/amortization dilution from the Galderma stake (USD ~450m p.a. PPA impact). Overall, the positives (broad growth, record margins, innovation and e‑commerce momentum, clear plan to keep investing) outweigh the negatives, which are largely strategic investments, timing effects and accounting impacts rather than indications of a structural earnings deterioration.View all LRLCY earnings summaries
                      Similar Stocks
                      Company
                      Price & Change
                      Follow
                      Colgate-Palmolive
                      The Estée Lauder Companies
                      Procter & Gamble
                      Unilever
                      Coty

                      Ownership Overview

                      0.01%<0.01%99.97%
                      Insiders
                      <0.01% Other Institutional Investors
                      99.97% Public Companies and
                      Individual Investors
                      Popular Stocks